30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Adolor Corp (ADLR)

Track

Stock chart
Ticker: ADLR Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
CUBIST PHARMACEUTICALS INC
1 purchase — total 33,612,090 USD
Buy 12 Dec 2011
Value US$4,970,542.60 | Price 214.93 | Shares 69,647
Buy 9 Dec 2011
Value US$2,284,185.10 | Price 280.46 | Shares 64,704
Buy 9 Dec 2011
Value US$3,239,080.56 | Price 40.67 | Shares 9,609
Buy 8 Dec 2011
Value US$5,019,177.75 | Price 4.25 | Shares 1,180,983
Buy 7 Dec 2011
Value US$18,301,048.25 | Price 4.25 | Shares 4,306,129
Buy 6 Dec 2011
Value US$85,860.50 | Price 4.66 | Shares 18,425
Buy 6 Dec 2011
Value US$286,672.50 | Price 4.65 | Shares 61,650
Buy 2 Dec 2011
Value US$161,700.00 | Price 4.62 | Shares 35,000
Buy 2 Dec 2011
Value US$467,000.00 | Price 4.67 | Shares 100,000
Buy 2 Dec 2011
Value US$344,798.08 | Price 4.73 | Shares 72,896
Buy 22 Nov 2011
Value US$12,104.94 | Price 4.58 | Shares 2,643
Buy 21 Nov 2011
Value US$112,275.99 | Price 4.59 | Shares 24,461
Buy 27 Jun 2011
Value US$18,800.00 | Price 1.88 | Shares 10,000
Buy 15 Jun 2011
Value US$5,418.00 | Price 1.80 | Shares 3,010
Buy 14 Jun 2011
Value US$25,061.00 | Price 1.90 | Shares 13,190
Buy 23 Dec 2010
Value US$35,400.00 | Price 1.18 | Shares 30,000
Sale 29 Oct 2010
Value US$444.81 | Price 1.18 | Shares 376
Sale 29 Oct 2010
Value US$16.56 | Price 1.18 | Shares 14
Sale 29 Oct 2010
Value US$1,045.77 | Price 1.18 | Shares 884
Sale 29 Oct 2010
Value US$70.98 | Price 1.18 | Shares 60
Sale 29 Oct 2010
Value US$37,460.88 | Price 1.18 | Shares 31,666
Sale 28 Oct 2010
Value US$1,051.73 | Price 1.19 | Shares 885
Sale 28 Oct 2010
Value US$39.22 | Price 1.19 | Shares 33
Sale 28 Oct 2010
Value US$2,479.00 | Price 1.19 | Shares 2,086
Sale 28 Oct 2010
Value US$168.75 | Price 1.19 | Shares 142
Sale 28 Oct 2010
Value US$88,737.83 | Price 1.19 | Shares 74,670
Sale 27 Oct 2010
Value US$739.70 | Price 1.30 | Shares 569
Sale 27 Oct 2010
Value US$297.54 | Price 1.28 | Shares 233
Sale 27 Oct 2010
Value US$27.30 | Price 1.30 | Shares 21
Sale 27 Oct 2010
Value US$11.49 | Price 1.28 | Shares 9
Sale 27 Oct 2010
Value US$1,743.30 | Price 1.30 | Shares 1,341
Sale 27 Oct 2010
Value US$702.35 | Price 1.28 | Shares 550
Sale 27 Oct 2010
Value US$118.30 | Price 1.30 | Shares 91
Sale 27 Oct 2010
Value US$47.25 | Price 1.28 | Shares 37
Sale 27 Oct 2010
Value US$62,371.40 | Price 1.30 | Shares 47,978
Sale 27 Oct 2010
Value US$25,119.87 | Price 1.28 | Shares 19,671
Buy 1 Jun 2010
Value US$3,536.04 | Price 1.58 | Shares 2,238
Buy 1 Jun 2010
Value US$664,736.02 | Price 1.64 | Shares 405,401
Buy 1 Jun 2010
Value US$97.96 | Price 1.58 | Shares 62
Buy 1 Jun 2010
Value US$18,348.24 | Price 1.64 | Shares 11,190
Buy 28 May 2010
Value US$33,749.77 | Price 1.56 | Shares 21,604
Buy 28 May 2010
Value US$828,409.50 | Price 1.60 | Shares 517,045
Buy 28 May 2010
Value US$931.07 | Price 1.56 | Shares 596
Buy 28 May 2010
Value US$22,866.60 | Price 1.60 | Shares 14,272
Buy 27 May 2010
Value US$71,640.13 | Price 1.60 | Shares 44,862
Buy 27 May 2010
Value US$1,976.96 | Price 1.60 | Shares 1,238
Buy 26 May 2010
Value US$102,195.89 | Price 1.59 | Shares 64,420
Buy 26 May 2010
Value US$2,820.62 | Price 1.59 | Shares 1,778
Buy 25 May 2010
Value US$109,558.45 | Price 1.60 | Shares 68,534
Buy 25 May 2010
Value US$3,024.55 | Price 1.60 | Shares 1,892
Buy 30 Apr 2010
Value US$1,927.97 | Price 1.99 | Shares 970
Buy 30 Apr 2010
Value US$69,824.39 | Price 1.99 | Shares 35,130
Buy 29 Apr 2010
Value US$240.40 | Price 1.94 | Shares 124
Buy 29 Apr 2010
Value US$8,739.66 | Price 1.94 | Shares 4,508
Buy 28 Apr 2010
Value US$5,938.31 | Price 1.92 | Shares 3,094
Buy 28 Apr 2010
Value US$1,752.96 | Price 1.82 | Shares 962
Buy 28 Apr 2010
Value US$215,165.05 | Price 1.92 | Shares 112,106
Buy 28 Apr 2010
Value US$63,481.80 | Price 1.82 | Shares 34,838
Buy 27 Apr 2010
Value US$201.87 | Price 2.06 | Shares 98
Buy 27 Apr 2010
Value US$451.29 | Price 2.08 | Shares 217
Buy 27 Apr 2010
Value US$1,267.27 | Price 2.08 | Shares 609
Buy 27 Apr 2010
Value US$1,015.90 | Price 2.08 | Shares 489
Buy 27 Apr 2010
Value US$7,312.64 | Price 2.06 | Shares 3,550
Buy 27 Apr 2010
Value US$16,342.28 | Price 2.08 | Shares 7,858
Buy 27 Apr 2010
Value US$45,894.25 | Price 2.08 | Shares 22,055
Buy 27 Apr 2010
Value US$36,790.45 | Price 2.08 | Shares 17,709
Buy 26 Apr 2010
Value US$2,508.77 | Price 2.05 | Shares 1,222
Buy 26 Apr 2010
Value US$22.66 | Price 2.06 | Shares 11
Buy 26 Apr 2010
Value US$2,885.04 | Price 2.07 | Shares 1,393
Buy 26 Apr 2010
Value US$327.54 | Price 2.06 | Shares 159
Buy 26 Apr 2010
Value US$90,861.67 | Price 2.05 | Shares 44,258
Buy 26 Apr 2010
Value US$801.34 | Price 2.06 | Shares 389
Buy 26 Apr 2010
Value US$104,489.07 | Price 2.07 | Shares 50,451
Buy 26 Apr 2010
Value US$11,855.30 | Price 2.06 | Shares 5,755
Sale 22 Sep 2009
Value US$280,971.60 | Price 1.69 | Shares 166,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2011-12-13 2011-12-12 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
69,647 +18.1%
214.93
US$4,970,543 		69,647 +18.1% 214.93 US$4,970,543
2011-12-13 2011-12-09 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
64,704 -8.3%
280.46
US$2,284,185 		64,704 -8.3% 280.46 US$2,284,185
2011-12-13 2011-12-09 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
9,609 -29.8%
40.67
US$3,239,081 		9,609 -29.8% 40.67 US$3,239,081
2011-12-09 2011-12-08 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
1,180,983 +2.9%
4.25
US$5,019,178 		1,180,983 +2.9% 4.25 US$5,019,178
2011-12-09 2011-12-07 B Purchase CUBIST PHARMACEUTICALS INC Large shareholder
4,306,129 +11.9%
4.25
US$18,301,048 		4,306,129 +11.9% 4.25 US$18,301,048
2011-12-08 2011-12-06 B Purchase MADDEN DAVID Non-Executive Director
18,425 +1.7%
4.66
US$85,860 		18,425 +1.7% 4.66 US$85,860
2011-12-08 2011-12-06 B Purchase MADDEN DAVID Non-Executive Director
61,650 +6.0%
4.65
US$286,672 		61,650 +6.0% 4.65 US$286,672
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
35,000 +11.4%
4.62
US$161,700 		35,000 +11.4% 4.62 US$161,700
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
100,000 +48.1%
4.67
US$467,000 		100,000 +48.1% 4.67 US$467,000
2011-12-02 2011-12-02 B Purchase NICKELSON DONALD E Non-Executive Director
72,896 +53.9%
4.73
US$344,798 		72,896 +53.9% 4.73 US$344,798
2011-11-30 2011-11-22 B Purchase NICKELSON DONALD E Non-Executive Director
2,643 +2.0%
4.58
US$12,105 		2,643 +2.0% 4.58 US$12,105
2011-11-30 2011-11-21 B Purchase NICKELSON DONALD E Non-Executive Director
24,461 +22.6%
4.59
US$112,276 		24,461 +22.6% 4.59 US$112,276
2011-06-27 2011-06-27 B Purchase Webster Stephen W

SVP, Finance & CFO

Officer
10,000 +7.8%
1.88
US$18,800 		10,000 +7.8% 1.88 US$18,800
2011-06-22 2011-06-15 B Purchase Limongelli John M

SVP, General Counsel & Secr.

Officer
3,010 +1.6%
1.80
US$5,418 		3,010 +1.6% 1.80 US$5,418
2011-06-22 2011-06-14 B Purchase Limongelli John M

SVP, General Counsel & Secr.

Officer
13,190 +7.6%
1.90
US$25,061 		13,190 +7.6% 1.90 US$25,061
2010-12-23 2010-12-23 B Purchase DOUGHERTY MICHAEL R

President & CEO

Executive Director
30,000 +5.1%
1.18
US$35,400 		30,000 +5.1% 1.18 US$35,400
2010-10-29 2010-10-29 S Sale Baker Biotech Capital (GP), LLC Large shareholder
376 -0.5%
1.18
US$445 		376 -0.5% 1.18 US$445
2010-10-29 2010-10-29 S Sale Baker Bros. Capital (GP), LLC Large shareholder
14 -0.5%
1.18
US$17 		14 -0.5% 1.18 US$17
2010-10-29 2010-10-29 S Sale 14159 capital (GP), LLC Large shareholder
884 -0.5%
1.18
US$1,046 		884 -0.5% 1.18 US$1,046
2010-10-29 2010-10-29 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
60 -0.5%
1.18
US$71 		60 -0.5% 1.18 US$71
2010-10-29 2010-10-29 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
31,666 -0.5%
1.18
US$37,461 		31,666 -0.5% 1.18 US$37,461
2010-10-29 2010-10-28 S Sale Baker Biotech Capital (GP), LLC Large shareholder
885 -1.1%
1.19
US$1,052 		885 -1.1% 1.19 US$1,052
2010-10-29 2010-10-28 S Sale Baker Bros. Capital (GP), LLC Large shareholder
33 -1.1%
1.19
US$39 		33 -1.1% 1.19 US$39
2010-10-29 2010-10-28 S Sale 14159 capital (GP), LLC Large shareholder
2,086 -1.1%
1.19
US$2,479 		2,086 -1.1% 1.19 US$2,479
2010-10-29 2010-10-28 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
142 -1.1%
1.19
US$169 		142 -1.1% 1.19 US$169
2010-10-29 2010-10-28 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
74,670 -1.1%
1.19
US$88,738 		74,670 -1.1% 1.19 US$88,738
2010-10-29 2010-10-27 S Sale Baker Biotech Capital (GP), LLC Large shareholder
569 -0.7%
1.30
US$740 		569 -0.7% 1.30 US$740
2010-10-29 2010-10-27 S Sale Baker Bros. Capital (GP), LLC Large shareholder
21 -0.7%
1.30
US$27 		21 -0.7% 1.30 US$27
2010-10-29 2010-10-27 S Sale 14159 capital (GP), LLC Large shareholder
1,341 -0.7%
1.30
US$1,743 		1,341 -0.7% 1.30 US$1,743
2010-10-29 2010-10-27 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
91 -0.7%
1.30
US$118 		91 -0.7% 1.30 US$118
2010-10-29 2010-10-27 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
47,978 -0.7%
1.30
US$62,371 		47,978 -0.7% 1.30 US$62,371
2010-10-29 2010-10-27 S Sale Baker Biotech Capital (GP), LLC Large shareholder
233 -0.3%
1.28
US$298 		233 -0.3% 1.28 US$298
2010-10-29 2010-10-27 S Sale Baker Bros. Capital (GP), LLC Large shareholder
9 -0.3%
1.28
US$11 		9 -0.3% 1.28 US$11
2010-10-29 2010-10-27 S Sale 14159 capital (GP), LLC Large shareholder
550 -0.3%
1.28
US$702 		550 -0.3% 1.28 US$702
2010-10-29 2010-10-27 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
37 -0.3%
1.28
US$47 		37 -0.3% 1.28 US$47
2010-10-29 2010-10-27 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
19,671 -0.3%
1.28
US$25,120 		19,671 -0.3% 1.28 US$25,120
2010-06-02 2010-06-01 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
2,238 +0.0%
1.58
US$3,536 		2,238 +0.0% 1.58 US$3,536
2010-06-02 2010-06-01 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
405,401 +6.3%
1.64
US$664,736 		405,401 +6.3% 1.64 US$664,736
2010-06-02 2010-06-01 B Purchase 14159 capital (GP), LLC Large shareholder
62 +0.0%
1.58
US$98 		62 +0.0% 1.58 US$98
2010-06-02 2010-06-01 B Purchase 14159 capital (GP), LLC Large shareholder
11,190 +6.2%
1.64
US$18,348 		11,190 +6.2% 1.64 US$18,348
2010-06-02 2010-05-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
21,604 +0.3%
1.56
US$33,750 		21,604 +0.3% 1.56 US$33,750
2010-06-02 2010-05-28 B Purchase 14159 capital (GP), LLC Large shareholder
596 +0.3%
1.56
US$931 		596 +0.3% 1.56 US$931
2010-06-02 2010-05-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
517,045 +8.8%
1.60
US$828,409 		517,045 +8.8% 1.60 US$828,409
2010-06-02 2010-05-28 B Purchase 14159 capital (GP), LLC Large shareholder
14,272 +8.6%
1.60
US$22,867 		14,272 +8.6% 1.60 US$22,867
2010-05-27 2010-05-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
44,862 +0.8%
1.60
US$71,640 		44,862 +0.8% 1.60 US$71,640
2010-05-27 2010-05-27 B Purchase 14159 capital (GP), LLC Large shareholder
1,238 +0.8%
1.60
US$1,977 		1,238 +0.8% 1.60 US$1,977
2010-05-27 2010-05-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
64,420 +1.1%
1.59
US$102,196 		64,420 +1.1% 1.59 US$102,196
2010-05-27 2010-05-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,778 +1.1%
1.59
US$2,821 		1,778 +1.1% 1.59 US$2,821
2010-05-27 2010-05-25 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
68,534 +1.2%
1.60
US$109,558 		68,534 +1.2% 1.60 US$109,558
2010-05-27 2010-05-25 B Purchase 14159 capital (GP), LLC Large shareholder
1,892 +1.2%
1.60
US$3,025 		1,892 +1.2% 1.60 US$3,025
2010-05-03 2010-04-30 B Purchase 14159 capital (GP), LLC Large shareholder
970 +0.6%
1.99
US$1,928 		970 +0.6% 1.99 US$1,928
2010-05-03 2010-04-30 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
35,130 +0.6%
1.99
US$69,824 		35,130 +0.6% 1.99 US$69,824
2010-05-03 2010-04-29 B Purchase 14159 capital (GP), LLC Large shareholder
124 +0.1%
1.94
US$240 		124 +0.1% 1.94 US$240
2010-05-03 2010-04-29 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
4,508 +0.1%
1.94
US$8,740 		4,508 +0.1% 1.94 US$8,740
2010-04-28 2010-04-28 B Purchase 14159 capital (GP), LLC Large shareholder
3,094 +2.0%
1.92
US$5,938 		3,094 +2.0% 1.92 US$5,938
2010-04-28 2010-04-28 B Purchase 14159 capital (GP), LLC Large shareholder
962 +0.6%
1.82
US$1,753 		962 +0.6% 1.82 US$1,753
2010-04-28 2010-04-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
112,106 +2.0%
1.92
US$215,165 		112,106 +2.0% 1.92 US$215,165
2010-04-28 2010-04-28 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
34,838 +0.6%
1.82
US$63,482 		34,838 +0.6% 1.82 US$63,482
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
98 +0.1%
2.06
US$202 		98 +0.1% 2.06 US$202
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
217 +0.1%
2.08
US$451 		217 +0.1% 2.08 US$451
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
609 +0.4%
2.08
US$1,267 		609 +0.4% 2.08 US$1,267
2010-04-28 2010-04-27 B Purchase 14159 capital (GP), LLC Large shareholder
489 +0.3%
2.08
US$1,016 		489 +0.3% 2.08 US$1,016
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
3,550 +0.1%
2.06
US$7,313 		3,550 +0.1% 2.06 US$7,313
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
7,858 +0.1%
2.08
US$16,342 		7,858 +0.1% 2.08 US$16,342
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
22,055 +0.4%
2.08
US$45,894 		22,055 +0.4% 2.08 US$45,894
2010-04-28 2010-04-27 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
17,709 +0.3%
2.08
US$36,790 		17,709 +0.3% 2.08 US$36,790
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,222 +0.8%
2.05
US$2,509 		1,222 +0.8% 2.05 US$2,509
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
11 +0.0%
2.06
US$23 		11 +0.0% 2.06 US$23
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
1,393 +0.9%
2.07
US$2,885 		1,393 +0.9% 2.07 US$2,885
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
44,258 +0.8%
2.05
US$90,862 		44,258 +0.8% 2.05 US$90,862
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
389 +0.0%
2.06
US$801 		389 +0.0% 2.06 US$801
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
50,451 +0.9%
2.07
US$104,489 		50,451 +0.9% 2.07 US$104,489
2010-04-28 2010-04-26 B Purchase 14159 capital (GP), LLC Large shareholder
159 +0.1%
2.06
US$328 		159 +0.1% 2.06 US$328
2010-04-28 2010-04-26 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
5,755 +0.1%
2.06
US$11,855 		5,755 +0.1% 2.06 US$11,855
2009-09-24 2009-09-22 S Sale BVF PARTNERS L P/IL

Direct Beneficial Owner

Large shareholder
166,000 -3.9%
1.69
US$280,972 		166,000 -3.9% 1.69 US$280,972
Explore more

More insider trading research around Adolor Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America